nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—skin cancer	0.695	1	CbGaD
Oxaprozin—CYP2C9—Vismodegib—skin cancer	0.0641	0.738	CbGbCtD
Oxaprozin—CYP2C9—Fluorouracil—skin cancer	0.0228	0.262	CbGbCtD
Oxaprozin—PTGS2—leg—skin cancer	0.00333	0.125	CbGeAlD
Oxaprozin—PTGS2—hindlimb—skin cancer	0.00297	0.112	CbGeAlD
Oxaprozin—PTGS2—appendage—skin cancer	0.00255	0.0957	CbGeAlD
Oxaprozin—PTGS2—skin epidermis—skin cancer	0.00212	0.0796	CbGeAlD
Oxaprozin—PTGS1—endothelium—skin cancer	0.00161	0.0605	CbGeAlD
Oxaprozin—PTGS2—endothelium—skin cancer	0.00154	0.0578	CbGeAlD
Oxaprozin—PTGS1—blood vessel—skin cancer	0.00148	0.0558	CbGeAlD
Oxaprozin—PTGS2—blood vessel—skin cancer	0.00142	0.0533	CbGeAlD
Oxaprozin—PTGS1—nipple—skin cancer	0.00107	0.0403	CbGeAlD
Oxaprozin—PTGS1—connective tissue—skin cancer	0.000761	0.0286	CbGeAlD
Oxaprozin—PTGS2—connective tissue—skin cancer	0.000728	0.0273	CbGeAlD
Oxaprozin—PTGS1—epithelium—skin cancer	0.000723	0.0271	CbGeAlD
Oxaprozin—PTGS2—epithelium—skin cancer	0.000691	0.0259	CbGeAlD
Oxaprozin—PTGS1—skin of body—skin cancer	0.000687	0.0258	CbGeAlD
Oxaprozin—PTGS2—skin of body—skin cancer	0.000657	0.0247	CbGeAlD
Oxaprozin—PTGS1—mammalian vulva—skin cancer	0.000627	0.0235	CbGeAlD
Oxaprozin—CYP2C9—female reproductive system—skin cancer	0.000588	0.0221	CbGeAlD
Oxaprozin—Pancytopenia—Temozolomide—skin cancer	0.000565	0.00295	CcSEcCtD
Oxaprozin—Oedema—Imiquimod—skin cancer	0.000564	0.00295	CcSEcCtD
Oxaprozin—Haemorrhage—Bleomycin—skin cancer	0.000564	0.00295	CcSEcCtD
Oxaprozin—Infection—Imiquimod—skin cancer	0.000561	0.00293	CcSEcCtD
Oxaprozin—Dysuria—Temozolomide—skin cancer	0.000556	0.00291	CcSEcCtD
Oxaprozin—Shock—Imiquimod—skin cancer	0.000555	0.0029	CcSEcCtD
Oxaprozin—Tachycardia—Imiquimod—skin cancer	0.000551	0.00288	CcSEcCtD
Oxaprozin—Agranulocytosis—Dactinomycin—skin cancer	0.000547	0.00286	CcSEcCtD
Oxaprozin—Sepsis—Docetaxel—skin cancer	0.000547	0.00286	CcSEcCtD
Oxaprozin—Hyperhidrosis—Imiquimod—skin cancer	0.000545	0.00285	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Temozolomide—skin cancer	0.000543	0.00284	CcSEcCtD
Oxaprozin—Eosinophilia—Fluorouracil—skin cancer	0.000542	0.00284	CcSEcCtD
Oxaprozin—Anorexia—Imiquimod—skin cancer	0.000538	0.00281	CcSEcCtD
Oxaprozin—PTGS1—female reproductive system—skin cancer	0.000537	0.0202	CbGeAlD
Oxaprozin—Hyperglycaemia—Temozolomide—skin cancer	0.000536	0.00281	CcSEcCtD
Oxaprozin—Pneumonia—Temozolomide—skin cancer	0.000533	0.00279	CcSEcCtD
Oxaprozin—PTGS2—lymphoid tissue—skin cancer	0.000532	0.02	CbGeAlD
Oxaprozin—Hepatitis—Dactinomycin—skin cancer	0.000526	0.00275	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000526	0.00275	CcSEcCtD
Oxaprozin—Body temperature increased—Vemurafenib—skin cancer	0.000523	0.00274	CcSEcCtD
Oxaprozin—Pancytopenia—Fluorouracil—skin cancer	0.00052	0.00272	CcSEcCtD
Oxaprozin—Stomatitis—Temozolomide—skin cancer	0.000517	0.0027	CcSEcCtD
Oxaprozin—PTGS2—female reproductive system—skin cancer	0.000513	0.0193	CbGeAlD
Oxaprozin—Deafness—Docetaxel—skin cancer	0.000511	0.00268	CcSEcCtD
Oxaprozin—Insomnia—Imiquimod—skin cancer	0.00051	0.00267	CcSEcCtD
Oxaprozin—Hepatic failure—Docetaxel—skin cancer	0.000509	0.00266	CcSEcCtD
Oxaprozin—Paraesthesia—Imiquimod—skin cancer	0.000507	0.00265	CcSEcCtD
Oxaprozin—Cardiac failure congestive—Docetaxel—skin cancer	0.000504	0.00264	CcSEcCtD
Oxaprozin—Dyspnoea—Imiquimod—skin cancer	0.000503	0.00263	CcSEcCtD
Oxaprozin—Somnolence—Imiquimod—skin cancer	0.000502	0.00262	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Fluorouracil—skin cancer	0.0005	0.00262	CcSEcCtD
Oxaprozin—Alopecia—Bleomycin—skin cancer	0.000499	0.00261	CcSEcCtD
Oxaprozin—Erythema multiforme—Dactinomycin—skin cancer	0.000498	0.0026	CcSEcCtD
Oxaprozin—Sinusitis—Temozolomide—skin cancer	0.000497	0.0026	CcSEcCtD
Oxaprozin—Dyspepsia—Imiquimod—skin cancer	0.000497	0.0026	CcSEcCtD
Oxaprozin—Pneumonia—Fluorouracil—skin cancer	0.000491	0.00257	CcSEcCtD
Oxaprozin—Decreased appetite—Imiquimod—skin cancer	0.00049	0.00257	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Fluorouracil—skin cancer	0.000482	0.00252	CcSEcCtD
Oxaprozin—Renal impairment—Docetaxel—skin cancer	0.000481	0.00251	CcSEcCtD
Oxaprozin—Myocardial infarction—Fluorouracil—skin cancer	0.000479	0.0025	CcSEcCtD
Oxaprozin—Haemoglobin—Temozolomide—skin cancer	0.000478	0.0025	CcSEcCtD
Oxaprozin—Stomatitis—Fluorouracil—skin cancer	0.000476	0.00249	CcSEcCtD
Oxaprozin—Haemorrhage—Temozolomide—skin cancer	0.000476	0.00249	CcSEcCtD
Oxaprozin—Hepatitis—Temozolomide—skin cancer	0.000476	0.00249	CcSEcCtD
Oxaprozin—Conjunctivitis—Fluorouracil—skin cancer	0.000475	0.00248	CcSEcCtD
Oxaprozin—Asthenia—Vemurafenib—skin cancer	0.000475	0.00248	CcSEcCtD
Oxaprozin—Hallucination—Temozolomide—skin cancer	0.000474	0.00248	CcSEcCtD
Oxaprozin—Pruritus—Vemurafenib—skin cancer	0.000468	0.00245	CcSEcCtD
Oxaprozin—Lethargy—Docetaxel—skin cancer	0.000467	0.00244	CcSEcCtD
Oxaprozin—Alopecia—Dactinomycin—skin cancer	0.000465	0.00243	CcSEcCtD
Oxaprozin—Feeling abnormal—Imiquimod—skin cancer	0.000465	0.00243	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Imiquimod—skin cancer	0.000461	0.00241	CcSEcCtD
Oxaprozin—Sinusitis—Fluorouracil—skin cancer	0.000458	0.0024	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000458	0.00239	CcSEcCtD
Oxaprozin—Agranulocytosis—Fluorouracil—skin cancer	0.000456	0.00238	CcSEcCtD
Oxaprozin—Ill-defined disorder—Bleomycin—skin cancer	0.000456	0.00238	CcSEcCtD
Oxaprozin—Anaemia—Bleomycin—skin cancer	0.000454	0.00237	CcSEcCtD
Oxaprozin—Diarrhoea—Vemurafenib—skin cancer	0.000453	0.00237	CcSEcCtD
Oxaprozin—Erythema multiforme—Temozolomide—skin cancer	0.00045	0.00235	CcSEcCtD
Oxaprozin—PTGS1—head—skin cancer	0.000449	0.0168	CbGeAlD
Oxaprozin—Urticaria—Imiquimod—skin cancer	0.000448	0.00234	CcSEcCtD
Oxaprozin—Abdominal pain—Imiquimod—skin cancer	0.000446	0.00233	CcSEcCtD
Oxaprozin—Body temperature increased—Imiquimod—skin cancer	0.000446	0.00233	CcSEcCtD
Oxaprozin—Tinnitus—Temozolomide—skin cancer	0.000444	0.00232	CcSEcCtD
Oxaprozin—Malaise—Bleomycin—skin cancer	0.000443	0.00232	CcSEcCtD
Oxaprozin—Haemoglobin—Fluorouracil—skin cancer	0.000441	0.00231	CcSEcCtD
Oxaprozin—Leukopenia—Bleomycin—skin cancer	0.00044	0.0023	CcSEcCtD
Oxaprozin—Haemorrhage—Fluorouracil—skin cancer	0.000439	0.00229	CcSEcCtD
Oxaprozin—Dizziness—Vemurafenib—skin cancer	0.000438	0.00229	CcSEcCtD
Oxaprozin—PTGS2—head—skin cancer	0.000429	0.0161	CbGeAlD
Oxaprozin—Ill-defined disorder—Dactinomycin—skin cancer	0.000425	0.00222	CcSEcCtD
Oxaprozin—Anaemia—Dactinomycin—skin cancer	0.000423	0.00221	CcSEcCtD
Oxaprozin—Vomiting—Vemurafenib—skin cancer	0.000421	0.0022	CcSEcCtD
Oxaprozin—Alopecia—Temozolomide—skin cancer	0.000421	0.0022	CcSEcCtD
Oxaprozin—Abdominal pain upper—Docetaxel—skin cancer	0.000418	0.00219	CcSEcCtD
Oxaprozin—Rash—Vemurafenib—skin cancer	0.000417	0.00218	CcSEcCtD
Oxaprozin—Dermatitis—Vemurafenib—skin cancer	0.000417	0.00218	CcSEcCtD
Oxaprozin—Headache—Vemurafenib—skin cancer	0.000414	0.00217	CcSEcCtD
Oxaprozin—Discomfort—Bleomycin—skin cancer	0.000413	0.00216	CcSEcCtD
Oxaprozin—Malaise—Dactinomycin—skin cancer	0.000413	0.00216	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000412	0.00216	CcSEcCtD
Oxaprozin—Leukopenia—Dactinomycin—skin cancer	0.00041	0.00214	CcSEcCtD
Oxaprozin—Fenbufen—PTGS2—skin cancer	0.000408	0.49	CrCbGaD
Oxaprozin—Dysgeusia—Temozolomide—skin cancer	0.000406	0.00212	CcSEcCtD
Oxaprozin—Asthenia—Imiquimod—skin cancer	0.000405	0.00212	CcSEcCtD
Oxaprozin—Confusional state—Bleomycin—skin cancer	0.000404	0.00211	CcSEcCtD
Oxaprozin—Anaphylactic shock—Bleomycin—skin cancer	0.000401	0.0021	CcSEcCtD
Oxaprozin—Oedema—Bleomycin—skin cancer	0.000401	0.0021	CcSEcCtD
Oxaprozin—Pruritus—Imiquimod—skin cancer	0.000399	0.00209	CcSEcCtD
Oxaprozin—Infection—Bleomycin—skin cancer	0.000398	0.00208	CcSEcCtD
Oxaprozin—Nausea—Vemurafenib—skin cancer	0.000393	0.00206	CcSEcCtD
Oxaprozin—Thrombocytopenia—Bleomycin—skin cancer	0.000392	0.00205	CcSEcCtD
Oxaprozin—Arrhythmia—Fluorouracil—skin cancer	0.000392	0.00205	CcSEcCtD
Oxaprozin—Vision blurred—Temozolomide—skin cancer	0.00039	0.00204	CcSEcCtD
Oxaprozin—Tremor—Temozolomide—skin cancer	0.000388	0.00203	CcSEcCtD
Oxaprozin—Alopecia—Fluorouracil—skin cancer	0.000388	0.00203	CcSEcCtD
Oxaprozin—Diarrhoea—Imiquimod—skin cancer	0.000386	0.00202	CcSEcCtD
Oxaprozin—Discomfort—Dactinomycin—skin cancer	0.000385	0.00202	CcSEcCtD
Oxaprozin—Ill-defined disorder—Temozolomide—skin cancer	0.000384	0.00201	CcSEcCtD
Oxaprozin—Anaemia—Temozolomide—skin cancer	0.000383	0.002	CcSEcCtD
Oxaprozin—Anorexia—Bleomycin—skin cancer	0.000382	0.002	CcSEcCtD
Oxaprozin—Angioedema—Temozolomide—skin cancer	0.000379	0.00198	CcSEcCtD
Oxaprozin—Pancytopenia—Docetaxel—skin cancer	0.000376	0.00196	CcSEcCtD
Oxaprozin—Hypotension—Bleomycin—skin cancer	0.000375	0.00196	CcSEcCtD
Oxaprozin—Oedema—Dactinomycin—skin cancer	0.000374	0.00196	CcSEcCtD
Oxaprozin—Malaise—Temozolomide—skin cancer	0.000374	0.00195	CcSEcCtD
Oxaprozin—Dizziness—Imiquimod—skin cancer	0.000373	0.00195	CcSEcCtD
Oxaprozin—Vertigo—Temozolomide—skin cancer	0.000372	0.00195	CcSEcCtD
Oxaprozin—Infection—Dactinomycin—skin cancer	0.000371	0.00194	CcSEcCtD
Oxaprozin—Leukopenia—Temozolomide—skin cancer	0.000371	0.00194	CcSEcCtD
Oxaprozin—Palpitations—Temozolomide—skin cancer	0.000366	0.00192	CcSEcCtD
Oxaprozin—Thrombocytopenia—Dactinomycin—skin cancer	0.000366	0.00191	CcSEcCtD
Oxaprozin—Paraesthesia—Bleomycin—skin cancer	0.00036	0.00188	CcSEcCtD
Oxaprozin—Vision blurred—Fluorouracil—skin cancer	0.00036	0.00188	CcSEcCtD
Oxaprozin—Convulsion—Temozolomide—skin cancer	0.000359	0.00188	CcSEcCtD
Oxaprozin—Vomiting—Imiquimod—skin cancer	0.000359	0.00188	CcSEcCtD
Oxaprozin—Hypertension—Temozolomide—skin cancer	0.000358	0.00187	CcSEcCtD
Oxaprozin—Dyspnoea—Bleomycin—skin cancer	0.000357	0.00187	CcSEcCtD
Oxaprozin—Anorexia—Dactinomycin—skin cancer	0.000356	0.00186	CcSEcCtD
Oxaprozin—Rash—Imiquimod—skin cancer	0.000356	0.00186	CcSEcCtD
Oxaprozin—Dermatitis—Imiquimod—skin cancer	0.000355	0.00186	CcSEcCtD
Oxaprozin—Pneumonia—Docetaxel—skin cancer	0.000355	0.00186	CcSEcCtD
Oxaprozin—Headache—Imiquimod—skin cancer	0.000353	0.00185	CcSEcCtD
Oxaprozin—Anaemia—Fluorouracil—skin cancer	0.000353	0.00185	CcSEcCtD
Oxaprozin—Anxiety—Temozolomide—skin cancer	0.000352	0.00184	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00035	0.00183	CcSEcCtD
Oxaprozin—Discomfort—Temozolomide—skin cancer	0.000349	0.00182	CcSEcCtD
Oxaprozin—Decreased appetite—Bleomycin—skin cancer	0.000348	0.00182	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Docetaxel—skin cancer	0.000348	0.00182	CcSEcCtD
Oxaprozin—Renal failure—Docetaxel—skin cancer	0.000347	0.00181	CcSEcCtD
Oxaprozin—Myocardial infarction—Docetaxel—skin cancer	0.000346	0.00181	CcSEcCtD
Oxaprozin—Dry mouth—Temozolomide—skin cancer	0.000345	0.0018	CcSEcCtD
Oxaprozin—Jaundice—Docetaxel—skin cancer	0.000344	0.0018	CcSEcCtD
Oxaprozin—Stomatitis—Docetaxel—skin cancer	0.000344	0.0018	CcSEcCtD
Oxaprozin—Conjunctivitis—Docetaxel—skin cancer	0.000343	0.00179	CcSEcCtD
Oxaprozin—Leukopenia—Fluorouracil—skin cancer	0.000342	0.00179	CcSEcCtD
Oxaprozin—Confusional state—Temozolomide—skin cancer	0.000341	0.00178	CcSEcCtD
Oxaprozin—Anaphylactic shock—Temozolomide—skin cancer	0.000338	0.00177	CcSEcCtD
Oxaprozin—Oedema—Temozolomide—skin cancer	0.000338	0.00177	CcSEcCtD
Oxaprozin—Infection—Temozolomide—skin cancer	0.000336	0.00176	CcSEcCtD
Oxaprozin—Nausea—Imiquimod—skin cancer	0.000335	0.00175	CcSEcCtD
Oxaprozin—Thrombocytopenia—Temozolomide—skin cancer	0.000331	0.00173	CcSEcCtD
Oxaprozin—Convulsion—Fluorouracil—skin cancer	0.000331	0.00173	CcSEcCtD
Oxaprozin—Feeling abnormal—Bleomycin—skin cancer	0.00033	0.00173	CcSEcCtD
Oxaprozin—Agranulocytosis—Docetaxel—skin cancer	0.000329	0.00172	CcSEcCtD
Oxaprozin—Hyperhidrosis—Temozolomide—skin cancer	0.000327	0.00171	CcSEcCtD
Oxaprozin—Decreased appetite—Dactinomycin—skin cancer	0.000325	0.0017	CcSEcCtD
Oxaprozin—Anorexia—Temozolomide—skin cancer	0.000322	0.00169	CcSEcCtD
Oxaprozin—Discomfort—Fluorouracil—skin cancer	0.000321	0.00168	CcSEcCtD
Oxaprozin—Urticaria—Bleomycin—skin cancer	0.000318	0.00167	CcSEcCtD
Oxaprozin—Haemoglobin—Docetaxel—skin cancer	0.000318	0.00166	CcSEcCtD
Oxaprozin—Body temperature increased—Bleomycin—skin cancer	0.000317	0.00166	CcSEcCtD
Oxaprozin—Haemorrhage—Docetaxel—skin cancer	0.000317	0.00166	CcSEcCtD
Oxaprozin—Hepatitis—Docetaxel—skin cancer	0.000317	0.00166	CcSEcCtD
Oxaprozin—Confusional state—Fluorouracil—skin cancer	0.000314	0.00164	CcSEcCtD
Oxaprozin—PTGS1—lymph node—skin cancer	0.000314	0.0118	CbGeAlD
Oxaprozin—Oedema—Fluorouracil—skin cancer	0.000312	0.00163	CcSEcCtD
Oxaprozin—Anaphylactic shock—Fluorouracil—skin cancer	0.000312	0.00163	CcSEcCtD
Oxaprozin—Infection—Fluorouracil—skin cancer	0.00031	0.00162	CcSEcCtD
Oxaprozin—Feeling abnormal—Dactinomycin—skin cancer	0.000308	0.00161	CcSEcCtD
Oxaprozin—Insomnia—Temozolomide—skin cancer	0.000306	0.0016	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000306	0.0016	CcSEcCtD
Oxaprozin—Thrombocytopenia—Fluorouracil—skin cancer	0.000305	0.0016	CcSEcCtD
Oxaprozin—Tachycardia—Fluorouracil—skin cancer	0.000304	0.00159	CcSEcCtD
Oxaprozin—Paraesthesia—Temozolomide—skin cancer	0.000304	0.00159	CcSEcCtD
Oxaprozin—Dyspnoea—Temozolomide—skin cancer	0.000301	0.00158	CcSEcCtD
Oxaprozin—Somnolence—Temozolomide—skin cancer	0.000301	0.00157	CcSEcCtD
Oxaprozin—PTGS2—lymph node—skin cancer	0.0003	0.0113	CbGeAlD
Oxaprozin—Erythema multiforme—Docetaxel—skin cancer	0.000299	0.00157	CcSEcCtD
Oxaprozin—Dyspepsia—Temozolomide—skin cancer	0.000298	0.00156	CcSEcCtD
Oxaprozin—Anorexia—Fluorouracil—skin cancer	0.000297	0.00155	CcSEcCtD
Oxaprozin—Abdominal pain—Dactinomycin—skin cancer	0.000296	0.00155	CcSEcCtD
Oxaprozin—Body temperature increased—Dactinomycin—skin cancer	0.000296	0.00155	CcSEcCtD
Oxaprozin—Decreased appetite—Temozolomide—skin cancer	0.000294	0.00154	CcSEcCtD
Oxaprozin—Hypotension—Fluorouracil—skin cancer	0.000291	0.00152	CcSEcCtD
Oxaprozin—Constipation—Temozolomide—skin cancer	0.000289	0.00151	CcSEcCtD
Oxaprozin—Asthenia—Bleomycin—skin cancer	0.000288	0.0015	CcSEcCtD
Oxaprozin—Pruritus—Bleomycin—skin cancer	0.000284	0.00148	CcSEcCtD
Oxaprozin—Arrhythmia—Docetaxel—skin cancer	0.000283	0.00148	CcSEcCtD
Oxaprozin—Insomnia—Fluorouracil—skin cancer	0.000282	0.00147	CcSEcCtD
Oxaprozin—Paraesthesia—Fluorouracil—skin cancer	0.00028	0.00146	CcSEcCtD
Oxaprozin—Alopecia—Docetaxel—skin cancer	0.00028	0.00146	CcSEcCtD
Oxaprozin—Feeling abnormal—Temozolomide—skin cancer	0.000279	0.00146	CcSEcCtD
Oxaprozin—Dyspnoea—Fluorouracil—skin cancer	0.000278	0.00145	CcSEcCtD
Oxaprozin—Somnolence—Fluorouracil—skin cancer	0.000277	0.00145	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Temozolomide—skin cancer	0.000277	0.00145	CcSEcCtD
Oxaprozin—Dyspepsia—Fluorouracil—skin cancer	0.000274	0.00143	CcSEcCtD
Oxaprozin—Decreased appetite—Fluorouracil—skin cancer	0.000271	0.00142	CcSEcCtD
Oxaprozin—Dysgeusia—Docetaxel—skin cancer	0.00027	0.00141	CcSEcCtD
Oxaprozin—Urticaria—Temozolomide—skin cancer	0.000269	0.00141	CcSEcCtD
Oxaprozin—Asthenia—Dactinomycin—skin cancer	0.000268	0.0014	CcSEcCtD
Oxaprozin—Abdominal pain—Temozolomide—skin cancer	0.000267	0.0014	CcSEcCtD
Oxaprozin—Body temperature increased—Temozolomide—skin cancer	0.000267	0.0014	CcSEcCtD
Oxaprozin—Feeling abnormal—Fluorouracil—skin cancer	0.000257	0.00134	CcSEcCtD
Oxaprozin—Diarrhoea—Dactinomycin—skin cancer	0.000256	0.00134	CcSEcCtD
Oxaprozin—Vomiting—Bleomycin—skin cancer	0.000255	0.00133	CcSEcCtD
Oxaprozin—Anaemia—Docetaxel—skin cancer	0.000255	0.00133	CcSEcCtD
Oxaprozin—Rash—Bleomycin—skin cancer	0.000253	0.00132	CcSEcCtD
Oxaprozin—Dermatitis—Bleomycin—skin cancer	0.000253	0.00132	CcSEcCtD
Oxaprozin—Urticaria—Fluorouracil—skin cancer	0.000248	0.00129	CcSEcCtD
Oxaprozin—Syncope—Docetaxel—skin cancer	0.000247	0.00129	CcSEcCtD
Oxaprozin—Leukopenia—Docetaxel—skin cancer	0.000247	0.00129	CcSEcCtD
Oxaprozin—Body temperature increased—Fluorouracil—skin cancer	0.000246	0.00129	CcSEcCtD
Oxaprozin—Palpitations—Docetaxel—skin cancer	0.000243	0.00127	CcSEcCtD
Oxaprozin—Asthenia—Temozolomide—skin cancer	0.000243	0.00127	CcSEcCtD
Oxaprozin—Loss of consciousness—Docetaxel—skin cancer	0.000242	0.00127	CcSEcCtD
Oxaprozin—Pruritus—Temozolomide—skin cancer	0.000239	0.00125	CcSEcCtD
Oxaprozin—Convulsion—Docetaxel—skin cancer	0.000239	0.00125	CcSEcCtD
Oxaprozin—Nausea—Bleomycin—skin cancer	0.000238	0.00125	CcSEcCtD
Oxaprozin—Hypertension—Docetaxel—skin cancer	0.000238	0.00124	CcSEcCtD
Oxaprozin—Vomiting—Dactinomycin—skin cancer	0.000238	0.00124	CcSEcCtD
Oxaprozin—Rash—Dactinomycin—skin cancer	0.000236	0.00123	CcSEcCtD
Oxaprozin—Phenylbutazone—PTGS2—skin cancer	0.000234	0.281	CrCbGaD
Oxaprozin—Diarrhoea—Temozolomide—skin cancer	0.000231	0.00121	CcSEcCtD
Oxaprozin—Dry mouth—Docetaxel—skin cancer	0.000229	0.0012	CcSEcCtD
Oxaprozin—Confusional state—Docetaxel—skin cancer	0.000227	0.00119	CcSEcCtD
Oxaprozin—Anaphylactic shock—Docetaxel—skin cancer	0.000225	0.00118	CcSEcCtD
Oxaprozin—Oedema—Docetaxel—skin cancer	0.000225	0.00118	CcSEcCtD
Oxaprozin—Dizziness—Temozolomide—skin cancer	0.000224	0.00117	CcSEcCtD
Oxaprozin—Infection—Docetaxel—skin cancer	0.000223	0.00117	CcSEcCtD
Oxaprozin—Nausea—Dactinomycin—skin cancer	0.000222	0.00116	CcSEcCtD
Oxaprozin—Shock—Docetaxel—skin cancer	0.000221	0.00116	CcSEcCtD
Oxaprozin—Pruritus—Fluorouracil—skin cancer	0.00022	0.00115	CcSEcCtD
Oxaprozin—Thrombocytopenia—Docetaxel—skin cancer	0.00022	0.00115	CcSEcCtD
Oxaprozin—Tachycardia—Docetaxel—skin cancer	0.000219	0.00115	CcSEcCtD
Oxaprozin—Vomiting—Temozolomide—skin cancer	0.000215	0.00112	CcSEcCtD
Oxaprozin—Anorexia—Docetaxel—skin cancer	0.000214	0.00112	CcSEcCtD
Oxaprozin—Rash—Temozolomide—skin cancer	0.000213	0.00112	CcSEcCtD
Oxaprozin—Diarrhoea—Fluorouracil—skin cancer	0.000213	0.00112	CcSEcCtD
Oxaprozin—Dermatitis—Temozolomide—skin cancer	0.000213	0.00111	CcSEcCtD
Oxaprozin—Headache—Temozolomide—skin cancer	0.000212	0.00111	CcSEcCtD
Oxaprozin—Hypotension—Docetaxel—skin cancer	0.00021	0.0011	CcSEcCtD
Oxaprozin—Dizziness—Fluorouracil—skin cancer	0.000206	0.00108	CcSEcCtD
Oxaprozin—Insomnia—Docetaxel—skin cancer	0.000203	0.00106	CcSEcCtD
Oxaprozin—Paraesthesia—Docetaxel—skin cancer	0.000202	0.00106	CcSEcCtD
Oxaprozin—Nausea—Temozolomide—skin cancer	0.000201	0.00105	CcSEcCtD
Oxaprozin—Dyspnoea—Docetaxel—skin cancer	0.0002	0.00105	CcSEcCtD
Oxaprozin—Somnolence—Docetaxel—skin cancer	0.0002	0.00105	CcSEcCtD
Oxaprozin—Vomiting—Fluorouracil—skin cancer	0.000198	0.00104	CcSEcCtD
Oxaprozin—Dyspepsia—Docetaxel—skin cancer	0.000198	0.00104	CcSEcCtD
Oxaprozin—Rash—Fluorouracil—skin cancer	0.000196	0.00103	CcSEcCtD
Oxaprozin—Dermatitis—Fluorouracil—skin cancer	0.000196	0.00103	CcSEcCtD
Oxaprozin—Decreased appetite—Docetaxel—skin cancer	0.000195	0.00102	CcSEcCtD
Oxaprozin—Headache—Fluorouracil—skin cancer	0.000195	0.00102	CcSEcCtD
Oxaprozin—Constipation—Docetaxel—skin cancer	0.000192	0.00101	CcSEcCtD
Oxaprozin—Flurbiprofen—PTGS2—skin cancer	0.000191	0.229	CrCbGaD
Oxaprozin—Feeling abnormal—Docetaxel—skin cancer	0.000185	0.000969	CcSEcCtD
Oxaprozin—Nausea—Fluorouracil—skin cancer	0.000185	0.000968	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Docetaxel—skin cancer	0.000184	0.000962	CcSEcCtD
Oxaprozin—Abdominal pain—Docetaxel—skin cancer	0.000178	0.00093	CcSEcCtD
Oxaprozin—Body temperature increased—Docetaxel—skin cancer	0.000178	0.00093	CcSEcCtD
Oxaprozin—Asthenia—Docetaxel—skin cancer	0.000161	0.000844	CcSEcCtD
Oxaprozin—Pruritus—Docetaxel—skin cancer	0.000159	0.000832	CcSEcCtD
Oxaprozin—Diarrhoea—Docetaxel—skin cancer	0.000154	0.000805	CcSEcCtD
Oxaprozin—Dizziness—Docetaxel—skin cancer	0.000149	0.000778	CcSEcCtD
Oxaprozin—Vomiting—Docetaxel—skin cancer	0.000143	0.000748	CcSEcCtD
Oxaprozin—Rash—Docetaxel—skin cancer	0.000142	0.000742	CcSEcCtD
Oxaprozin—Dermatitis—Docetaxel—skin cancer	0.000142	0.000741	CcSEcCtD
Oxaprozin—Headache—Docetaxel—skin cancer	0.000141	0.000737	CcSEcCtD
Oxaprozin—Nausea—Docetaxel—skin cancer	0.000134	0.000699	CcSEcCtD
